- Patient Information Writer and Researcher
- Salary: £35,000 p.a. + benefits
- Location: London
- Permanent, full-time role
- Closing date for applications: 30 October 2016
- Interview date: 9 November 2016
We’re Anthony Nolan and we save the lives of people with blood cancer who need a stem cell transplant.
We’re unique. Thanks to the incredible donors on our register, our pioneering research and our passionate fundraisers, we give the chance of life to three people a day.
But we won’t stop there. We want to be there for everyone who needs a transplant; from finding a match, through every step of a patient’s transplant journey. And together we can reach the remarkable day when we can save the lives of everyone with blood cancer.
And now we want you to join our lifesaving team. We are looking for a Patient Information Writer and Researcher to join our Patient Experience Team.
We are looking for someone to develop and implement Anthony Nolan’s information ‘offer’ including audience research and strategy into the services we provide. Our activity in this area needs to be co-ordinated, evaluated and sensitive to the needs and wishes of our patients and their families.
This person will also lead on the on going systematic review of evidence on all medical and scientific topics associated with transplant.
The right candidate will have extensive experience of writing patient information, establishing and evaluating new information services and importantly, will have experience of writing and reviewing scientific research.
Ideally the candidate will have either published research themselves or have been directly involved in the research evidence/review/production process.
Release your remarkable, join our team and give someone a chance of life.
The closing date for applications is 30 October 2016.
More information, including how to apply, can be found on the Anthony Nolan website.
Anthony Nolan is an equal opportunities & living wage accredited employer.
All applicants must be able to demonstrate the right to work in the UK.